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PART I
PARTIAL PURIFICATION OF INSULIN-LIKE
PEPTIDES FROM INSECTS
INTRODUCTION
This research was part of an overall study to determine
how insects regulate carbohydrate metabolism. First, we
wished to purify a hypotrehalosemic insulin-like factor from
insects. Part I describes methods for partially purifying
such a factor from the tobacco hornworm, Manduca sexta (L.)
and the honeybee, Apis mel ifera (L.). Second, we wanted to
examine effects of mammalian hypoglycemic agents on insect
development. Part 2 describes the action of two
sulfonylureas and a biguanide in the phytophagus insect M.
se xta and the stored-product insects, the Indian meal moth,
Plodia interpunctell a (Hubner) and the confused flour
beetle, Tribolium confusum (Jacguelin du Val). This work
supports the hypothesis that the hypotrehalosemic hormone
and an insulin-like peptide in insects are the same chemical
species and also demonstrates that drugs which affect
carbohydrate physiology in vertebrates also function in
insects
.
LITERATURE REVIEW
IilS.§.ct Carbohydrate Utilization and Metabolic Pathwa ys
A. Energy Storage and Utilization
Insect and vertebrate carbohydrate metabolisms are
similar. Both organisms utilize glucose as an energy source
and share important metabolic pathways (57-59) like glycogen
synthesis and degradation, glycolysis, the tricarboxylic
acid cycle, and the pentose phosphate pathway. Certain
insect enzymes, e.g. glycogen synthetase (57),
phosphor ructokinase (58), and pyruvate kinase (59), exhibit
biochemical similarities when compared to their vertebrate
counterparts
.
Insect and vertebrate carbohydrate metabolism also have
obvious differences. In insects, the fat body carries out
many functions that are divided between adipose tissue and
liver in vertebrates (13). The fat body stores lipids,
carbohydrates, and proteins and synthesizes many components
of the hemolymph. In many insects trehalose,
D-alpha-glucopyranosy 1 1- (1-1 ) -alpha-D glucopyranoside , acts
as a circulating source of stored carbohydrate, a kind of
miniglycogen , (Figure 1) (12). Trehalose synthesis occurs
in fat body. In the locust, Schistocerca gregaria (11),
synthesis depends on the following reaction sequence:
1. Glucose-6-P + UDP-glucose — > Trehalose-6-P + UDP
2. Trehalose-6-P + H 2 — > Trehalose + Pi
The enzyme, trehalose phosphate synthetase (UDP glucose:
Figure 1. The structure of trehalose, D-alpha
glucopyranosyl L- (1-1 ) -alpha-D glucopyranos ide.
CH20H
TREHALOSE
D-glucose-6-phosphate 1-glucosy ltransferase ) catalyzes
reaction 1. A phosphatase (trehalose-6-phosphate phospho-
hydrolase) catalyses reaction 2.
After synthesis and release into the hemolymph,
trehalose cannot be used for energy by the cells until it is
converted to glucose. The enzyme trehalase or trehalose
giucohydrolase hydrolyzes the disaccharide to release its
glucose components (12,13). The reaction catalyzed by
trehalase is as follows:
Trehalose + H 2 — > 2 D-glucose
Trehalase is widely distributed in many tissues such as
muscle, gut, fatbody, and hemolymph and has been found to be
both soluble and particulate in nature (54-56).
B. Regulation of Carbohydrate Metabolism
Current understanding of the factors regulating
concentration of blood trehalose and its metabolism is
limited. However, blood trehalose homeostasis has been
shown to be regulated (9,13) and appears to result from a
steady state between carbohydrate input and trehalose
synthesis on one hand, and sugar loss or utilization on the
other. Carbohydrate input into the system is derived from
both exogenous carbohydrate and gluconeogenesis . Studies on
trehalose synthesis have demonstrated its control at the
enzyme level. In the blowfly, Phormia regina , trehalose
inhibits its own synthesis by a feedback mechanism (60).
Studies of larval-cecropia trehalose phosphate synthetase
7showed end product inhibition of the enzyme by trehalose and
allosteric activation by glucose-6-phosphate (15).
Excretion of trehalose also appears to be regulated
(12, 61)
.
Several reports have presented evidence for the
presence of counter-regulatory hyper- and hypotreha losemic
hormones in insects. In 1961 Steele found a
hypertrehalosemic hormone in the neurosecretory system
(corpus cardiacum) of the cockroach, Periplaneta americana
.
Further studies characterized and confirmed the presence of
this factor in the corpus cardiacum of other insects. It
promoted glycogeno lysis and increased both trehalose
synthesis and its release into hemolymph. Its action was
comparable to glucagon in vertebrates (71,72). The
demonstration that purified extracts of this factor
cross-reacted with vertebrate glucagon antibodies provided
further evidence that the peptide was similar to glucagon
(70) .
In vertebrates, the antagonistic effects of the
hyperglycemic hormone, glucagon, and the hypoglycemic
hormone, insulin, are important determinants of blood
glucose levels (62). The presence of a glucagon-like
hypertrehalosemic and glycogenolytic factor in insects
implied that an insulin-like hypotrehalosemic factor might
also be present. In the past relatively little evidence had
been obtained suggesting a hypotrehalosemic factor in
insects. However, recently reports of an insulin-like
8hypotrehalosemic hormone in several insect species have
appeared. Seecof and Dewhurst (76) reported immunological
cross reactivity with bovine insulin antibody to a factor in
Drosophila melanogaster hemolymph. Whole body extracts of
Drosophila were shown to produce hypoglycemia in mice by
Meneses and Ortiz (84). In 1975, T. C. Norman (81)
suggested that hypertrehalosemia resulting from decapitation
of the blowfly, Calliphora ery throcephala , wa3 caused by
loss of a cephalic hypotrehalosemic hormone. A short time
later, Tager et al. (70) showed that purified aqueous
extracts of the neuroendocrine system of adult tobacco
hornworm, Manduca s exta
,
produced hypotrehalosemia when
injected into the larval form of the same species.
Radioimmunoanalysis of the material revealed an
immuno-reactive insulin-like component in the extract.
These reports and others described in Section III strongly
suggested the presence of an insulin-like peptide in insects
which functions similarly to vertebrate insulin.
Insulin
A. Structure
Banting and Best first isolated the hormone insulin
from dog pancreas in 1921 (32). It was not until the 1950's
that its amino acid sequence was determined by Sanger and
his colleagues (33). Insulin has a molecular weight in the
range of 6,000 daltons (63) depending on the species. Human
9and bovine insulin have molecular weights of 5,734 daltons
(129)
.
Insulin is composed of two polypeptide chains which are
designated A and B. The primary structure of human
proinsulin and insulin is shown in Figure 2. The seguences
of insulin from other species are guite similar (129). in
the insulin seguences from mammals, birds, and fishes which
are currently known, the A chain has 21 amino acid residues
and the B chain usually has 30. These chains are connected
to each other by two interchain and one intrachain disulfide
bond. In porcine insulin, the disulfide bonds are located
between cysteine residues at position A-7 and B-7, A-20 and
B-19, and A-6 and A-ll respectively. The interchain
disulfide bonds must be intact for biological activity and
appear to be conserved in insulins from all species studied
(120)
The three-dimensional structure of zinc crystalline
insulin was determined by Hodgkin and her coworkers using
X-ray crystallography (121,122). Hodgkin showed that the A
chain of the molecule is a compact unit around which the B
chain is wrapped. Insulin forms dimers and hexamers (107)
and sometimes has a zinc reguirement for crystallization
depending on the species (64).
When considering the evolutionary origin of insulin and
the possibility of insulin occurring in primitive organisms,
it is interesting to note differences and similarities
between hagfish and mammalian insulin. Hagfish insulin is
10
Figure 2. Human proinsulin and its conversion to insulin.
The amino acid sequence of porcine proinsulin is shown.
By proteolytic removal of four basic amino acids and the
C-peptide , proinsulin is converted to insulin (adapted
from Goodman and Gilman, 163).
11
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considered the most ancient insulin for which detailed
structural knowledge has been obtained. Although almost
half of the residues in the amino acid sequence of hagfish
insulin differ from those of human insulin, x-ray
crystallographic studies (67) have shown the molecular
backbone in hagfish insulin to be essentially identical to
mammalian insulin. Because of these similarities, it is
perhaps not unreasonable to expect that insulins from other
primitive animals such as insects are also similar to
mammalian insulin.
B. Synthesis
Steiner and associates (21,22) studied insulin
biosynthesis by incorporating C-leucine into an
insulin-producing tumor. Their studies demonstrated the
formation of a large precursor insulin molecule as part of
the biosynthetic process. This precursor, a single
polypeptide chain, was subsequently called proinsulin
(Figure 2) . Proteolytic cleavage of proinsulin between
amino acids 30 and 31 and at the N-terminal of the A chain
is required to release both insulin and a nonfunctional
connecting peptide (C-peptide) from the proinsulin molecule.
In many mammalian insulins a pair of basic amino 3cids on
either side of the connecting peptide link the C-peptide to
the A and B chains. Those amino acids are split out during
conversion of proinsulin to insulin and are not found in
insulin or the C-peptide.
13
The molecular weight of mammalian proinsulin ranges
around 9,000 daltons (63). Hagfish proinsulin is similar in
size to the proinsulins of higher species and its connecting
polypeptide segment is made of similar amino acids (68).
Mammalian insulin and its precursor proinsulin share
many immunologic determinants. Immunologic cross-reactivity
between insulin and proinsulin of the same species has been
demonstrated. However, a wide variation in the degree of
such cross-reactivity has been observed (19,34-38). in
general, most insulin antisera react less readily with
proinsulin than with insulin. The amount of proinsulin
biological activity that can be demonstrated also varies
from tissue to tissue (43) but is consistently lower than
that of insulin (41,42). It is likely that the proinsulin
connecting segment interferes with the binding of some
insulin antibodies or receptors to the insulin moiety or,
perhaps, attachment of the connecting segment to the A and B
chains decreases the affinity of insulin antibodies or
receptors for the insulin moiety by changing its three
dimensional structure.
Insulin is the first polypeptide hormone for which the
mechanism of biosynthesis was elucidated (21). Insulin
biosynthesis occurs in specialized endocrine, beta-cells. A
preproinsulin , consisting of proinsulin with an amino
terminal extension of approximately 2,500 daltons, is the
first polypeptide formed in the biosynthetic pathway. It
was discovered by in vitro translation of mRNA molecules
14
coded for producing insulin. A heterologous system lacking
proteolytic enzymes was used for the translation. During .in
vivo synthesis, the amino acid terminal extension of
proinsulin is rapidly cleaved off by proteolytic enzymes.
Consequently, preproinsul in is usually not observed in
vivo
.
C. Action
Hormones are substances produced by specialized cells
and released into the circulatory system to exert their
effect on target tissues. Hormone concentrations in the
blood are generally low. For example, in humans the normal
insulin concentration after fasting ranges from 0.2-3 ng/ml
(approximately .4-6 x 10 1- 3 M) (124). Most evidence
indicates that insulin affects cellular functions after it
binds to a cell surface receptor (16,17,18). However, the
detailed molecular mechanism is unknown (51,127). A recent
report (50) indicated the presence of insulin receptors in
cell nuclei, but their significance in insulin action has
not been ascertained.
In vertebrates insulin is an anabolic hormone and
primarily affects liver, muscle, and adipose tissue.
Insulin activates certain enzymes, e.g. glycogen synthetase
(18) and pyruvate dehydrogenase (125), and changes membrane
permeability (124). In liver, insulin increases lipid,
protein, and glycogen synthesis and decreases
gluconeogenesis (124). In muscle, insulin increases
15
glycogen synthesis, glucose uptake, amino acid uptake, and
protein synthesis (124). In adipose tissue, insulin
increases glucose uptake and triglyceride synthesis and
decreases triglyceride breakdown by lipase (124). In
addition to its anabolic effects, insulin has been shown to
accelerate cell differentiation in both vertebrate and
invertebrate tissue cultures (53-55).
Insulin-like Peptides jln I nsects
Early attempts to demonstrate a physiological response
in insects to vertebrate insulin yielded unexpected results,
probably because many insulin preparations used were
contaminated with glucagon. No depression of blood sugar
was observed in a 1924 study by Hemmingsen of the action of
vertebrate insulin in the butterfly Smerinthus ocel l atu s
(93) . Although Hemmingsen recorded the amount injected into
the butterfly as that of "1/10 of the rabbit dose," we have
been unable to determine the actual amount. Similar results
(lack of blood sugar depression) were obtained in a 1936
study (73) using the silkworm, Bombyx mori (L.) where 4 ug
insulin per insect was injected. The slight increase in
hemolymph sugar levels which was observed in these insects
was unexpected. Krahl (84) concluded in his review that
these responses were due to trace glucagon contamination of
the samples of insulin employed in these early studies.
Even today with more sophisticated isolation techniques,
16
unless extreme precaution is taken, commercial samples of
insulin are usually contaminated with glucagon (124).
More recently Bhaktan and Gilbert (74) demonstrated
that vertebrate insulin (20 ng insulin in 2 ml of hemolymph
per 150 to 200 mg fat body) inhibited diglyceride and free
fatty acid release in pupal fat body of the American
silkmoth, Hya lopho ra cecrop ia . This effect was similar to
the activity of insulin in vertebrates (124). In contrast,
Chang (75) found that vertebrate insulin (50 ug/ml)
exhibited the opposite effect in the monarch butterfly,
Danaus plexippus (L.) and sweetpotato hornworm, Agr ius
cingulat a (Fabricius). The hormone induced triglyceride,
diglyceride, and free fatty acid release from larval fat
body. The latter response was actually typical of
vertebrate glucagon (124) and perhaps the sample of insulin
used in this study was contaminated with glucagon.
In 1976, Ishay et al. (85) induced hypoglycemia in vivo
in oriental hornet larvae, Vespa orientalis using bovine
insulin injections (32 ug per insect). He also observed an
in v itro drop in glucose levels when bovine insulin (480 to
960 ug per ml of hemolymph, a whopping high amount) was
added to hemolymph which had been incubated with hornet
midgut. In 1978 Norman and Duve demonstrated
hypotrehalosemia (87) in the blowfly, Calliphora
e ry throcephala , after porcine insulin injection (8 ug per
insect). The experiments by Bhaktan and Gilbert (74), Ishay
et al. (85), and Norman and Duve (87) demonstrated that
17
vertebrate insulin can indeed affect certain insects in a
manner similar to its characteristic vertebrate action.
Insulin facilitates anabolic processes in vertebrates
by increasing glycogen, protein, and triglyceride synthesis
iH Y.i.vo (124). It has similar effects on vertebrate cells
in culture (79,80). The results of Seecof and Dewhurst (76)
demonstrate such effects on insect embryonic cells in
culture. Bovine insulin added to Drosophi la embryonic cells
facilitated cellular differentiation and anabolism. The
hormone (148 ng/ml) increased the number of muscle and
fat-containing cells and also the total protein content of
the culture by 50 percent.
Establishment of Drosophila cell lines in culture is
also facilitated by insulin. Normally the number of cell
lines obtained without insulin is very low, about one in
forty. In 1976, Mosna and Barigozzi (77) were able to
increase the number of cultures established by about four
times (to one in ten) by adding vertebrate insulin to the
culture medium. Concentrations of 74, 148, and 296 ng/ml
were used and all produced about the same response. In the
same year, Davis and Shearn (78) noted that mammalian
insulin (16 ng per ml) enhanced growth of Drosoph ila
imaginal discs in culture. Imaginal discs are
undifferentiated larval and pupal cells which form wings,
legs, and other organs of the adult.
The studies discussed heretofore revealed effects of
vertebrate insulin in various insects or insect tissues and
18
suggested that insulin is active in insects. Other
investigations have used bioassay and radioimmunoassay to
provide additional evidence for insulin-like peptides in
insects. Table 1 summarizes the results of such studies.
Insulin has been quantitated in extracts of whole body of
Drosophila melanogaste r (84), Cera t itis capitata (98), and
Apis melli fera (86); hemolymph from Drosophil a melanoga stor
(76) and Manduca sexta (Kramer 1977, unpublished); corpus
cardiacum and corpus allatum from M. sexta (70); gut tissue
from Locusta mig rator ia (85) and several hymenopteran
species (85); and royal jelly (82,83), worker jelly (82),
and gut tissue (85) from Ap_i§_ mell ifera . Levels detected
range from a ng to more than a ug per gm of tissue or ml of
hemolymph
.
The insulin-like peptide in royal jelly, a pharyngeal
secretion of the honeybee, Ap_i_s mellifera , was first studied
in 1964 (82). At that time, Dixit and Patel separated a
peptide from royal jelly using paper chromatography and
paper electrophoresis that had the same characteristics as
bovine insulin. It produced an insulin-like effect in rat
adipose tissue, increasing glucose utilization and
oxidation. Kramer et al. (83) found that injection of
aqueous extracts of royal jelly into M. sexta larvae caused
hypotrehalosemia
. Using insulin radioimmunoassay, the
latter authors also demonstrated the presence of an
insulin-like peptide in royal jelly that had been
delipidated, acid extracted and chromatographed on
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polyacry lamide gel. The major immunoreactive component,
which was 60 percent of the total immunoreact ivity assayed,
had an apparent molecular weight similar to bovine insulin.
In 1975, Norman (81) suggesed that hypertrehalosemia
resulting from decapitation of the blowfly, Calliphora
erythrocephala , was due to a lack of hypotreha losemic
hormone of cephalic origin. The cephalic neuroendocrine
gland complex, the corpus cardiacum-corpus allatum (CC-CA),
was a likely source of this hormone. Other investigators
have also demonstrated hypertrehalosemia in insects after
selective removal of the corpus cardiacum of the blowfly,
Phormia regina , (97) or of the CC-CA in the housefly, Musca
domestica , (L.) (96). Partially purified immunoreactive
insulin from M. sexta CC-CA complex also caused
hy potrehalosemia when injected into M. sexta larvae (70).
Like the findings for royal jelly (83), the elution volume
of the major immunoreactive insulin component from gel
filtration of extracts of the CC-CA complex was essentially
the same as that of bovine insulin. This insulin like
peptide may be similar to the cephalic hypotreha losemic
hormone in the blowfly originally hypothesized by Norman in
1975. Its identification adds to the increasing evidence
for a functioning insulin in insects.
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MATERIALS AND METHODS
IHUiiill Radioimmunoassa y
The Insulin radioimmunoassay kit and thimerosal were
purchased from ICN Medical Laboratories Inc., Portland,
Oregon (ICN). The radioimmunoassay (RIA) procedure measures
insulin content by comparing the competitive binding of i ^ J i
labeled porcine insulin and unlabeled insulin-like peptide
with an antibody to insulin, an anti-porcine insulin
immunoglobulin. The assay measured amounts of porcine
insulin as low as 0.5 ng
.
The reagents were prepared as follows: five g of
bovine serum albumin, BSA, was added to 500 ml of 0.1M
sodium borate buffer and 0.5 g thimerosal mixed to form the
1 percent BSA borate solution. The final pH of the solution
was 7.4. Aliquots of insulin standard solution (512 mu/ml
,
porcine) were mixed with 1 percent BSA borate solution to
obtain 256, 128, 64, 32, 16, 8, 4, 2, and uU/ml solutions
of insulin for determining the standard curve. By
convention 1 mg bovine or porcine insulin represented 25
units of activity (125). Two milliliters of ca 25 uCi/ml of
12 5 I-porcine insulin solution were mixed with 100 ml of a 1
percent BSA borate solution to form the tracer solution.
Five milliliters of the guinea pig anti-porcine insulin
serum was dissolved in 98 ml of 1 percent BSA borate
solution to form the insulin first antibody solution.
Ten milliliters of rabbit anti-guinea pig serum was
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dissolved in 100 ml of 1 percent BSA borate solution to form
the second antibody solution.
All assays were performed in duplicate. To each
13 x 100 mm test tube 0.25 ml 1 percent BSA borate solution,
0.25 ml of a solution containing insulin standard or
unknown, 0.25 ml I-insulin solution, and 0.25 ml insulin
first antibody solution were added and vortexed. The tubes
were then incubated at room temperature for 16 to 18 hours.
Following incubation, 0.25 ml of second antibody,
anti-guinea pig serum solution was added to each tube, the
solution vortexed, and then incubated at room temperature
for an additional four hours. After centrifugation at 5,000
rpm (3,000 x g) in a Sorval RC2B for twenty minutes, the
supernatant was immediately transferred to a clean labeled
tube with a Pasteur pipette. One-half ml of the supernatant
was mixed with 15 ml of scintillation cocktail in a 20 ml
polyethylene scintillation vial (Fisher Scientific,
Pittsburgh, PA) and counted in a Searle Isocap 300 liquid
scintillation counter. The scintillation cocktail was
prepared by combining 1500 ml of scintillation grade toluene
(Yorktown, Hackensack, New Jersey) and 1500 ml low peroxide
methyl ceilosolve (Mallinckrodt , St. Louis, Missouri) with
12 g Preblend 2a70 (Research Products Incorporated, Elk
Grove Village Illinois, RPI). Preblend 2a70 contained 98
percent PPO ( 2, 5-dipheny loxazole) and 2 percent bis-MSB
(p-bis ( 0-me thy Is tyryl ) -benzene) .
The fraction of labeled insulin bound by the antibody,
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125percent bound I-insulin, was a function of the amount of
unlabeled insulin added to the reaction mixture. Assays
were performed to determine the cpm in an aliquot of the
supernatant of the sample or standard and the cpm in an
aliquot from a sample to which buffer was substituted for
antibody and unlabeled insulin solutions. The radioactivity
from the tube to which no antibody was added was used as a
1 2 5
measure of the total I-insulin added.
In general, the technique of radioimmunoassay depends
on binding of isotopically labeled antigen by an
antigen-specific antibody which is competitively inhibited
by addition of unlabeled antigen. The fraction of
radioactive antigen bound by the antibody is a quantitative
function of the amount of unlabeled antigen added to the
reaction mixture when the concentration of the antibody is
held constant. When the antibody-bound antigen is separated
from unbound or free antigen by precipitation with second
antibody directed against first antibody, the fraction of
labeled antigen bound to antibody was determined by counting
supernatant. A plot of the percent antibody bound-labeled
antigen against the quantity of unlabeled standard antigen
added to the incubation mixtures produces an exponential
curve. A more linear relationship over the useful range of
the assay is obtained if the concentration of standard is
plotted logarithmically . A semilogarithmic plot of a
standard curve from the ICN radioimmunoassay system used in
these studies is shown in Figure 3. The percent
25
Figure 3. Displacement curve for the ICN insulin
radioimmunoassay. The percent bound 125i-insu ii n has been
plotted vs. the logarithm of the concentration of insulin
for each standard solution.
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125 I-insulin binding for each unknown sample was fitted on a
standard curve to quantitate the amount of immunoreac tive
insulin in an unknown sample.
The Anti-Ins ulin Sepharos e Column
A. Preparation and Characterization
Two milliliters of goat anti-porcine insulin serum
(RPI) stored at -70°C were thawed and transferred from the
shipping vial to a centrifuge tube followed by a 2 ml
distilled water rinse. The anti-insulin immunoglobulin
fraction was precipitated by addition of 0.72 g of Na 2 S0 4 to
the solution (18 percent salt). The solution was
centrifuged at 5,000 rpm (3,000 x g) for five minutes and
the supernatant decanted away. The precipitate was
dissolved in distilled water and dialyzed against 0.14 M
NaCl for 24 hours 4°C. The cellulose nitrate dialysis
tubing (average radius permeability = 24 angstroms, VWR
Scientific, Kansas City, Kansas) was prepared by boiling in
1 mM ethylenediamine-tetraacetic acid (EDTA) for one half
hour and then in 1 mM sodium bicarbonate for one half hour.
The tubing was then rinsed well and stored in distilled
water at 4°C until use. After dialysis the total amount of
immunoglobulin in the dialysate was determined to be 14 mg
using E280 = ^ • -> m ^ c™/m9 (112) .
A 2.7 gm portion of CNBr- activated Sepharose 4B
(Pharmacia, Piscataway, New Jersey) was swelled with 540 ml
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1 mM HC1 solution for fifteen minutes, washed and filtered
dry using a sintered glass filter. Then dialyzed
immunoglobulin was immediately added to the beads in 15 ml
of coupling buffer (0.1 M NaHC0 3 , 0.5 percent NaCl pH 8.0)
and stirred gently for three hours . After filtering to
dryness the beads were then washed twice with coupling
buffer and finally with a solution of 1 M ethanolamine
,
0.1 M NaHC03 , 0.5 percent NaCl pH 8.0 for at least four
hours to react any left over electrophilic sites on the
beads. Noncovalently adsorbed proteins were removed by
first washing with 0.1 M NaOAc, 1 M NaCl, pH 4.0 buffer and
then with a 0.1 N Na 2B 2 4 , 1 M NaCl, pH = 8. The insulin
immunoglobulin coupled to Sepharose 4B (abreviated AIG-S)
was stored at 4°C in 20 ml of 0.1 M Na 2 B 2 4 , 1 M NaCl, pH
8.0 buffer containing 1 percent gentamicin sulfate
(Schering, New Jersey) as a preservative. The amount of
immunoglobulin coupled to the column was determined by
change in absorbance at 280 nm of the coupling buffer and
immunoglobulin solution before and after the coupling
procedure. Ninety-seven percent of the immunoglobulin was
coupled to the column.
The AIG-S was packed in a glass column filled with a
0.1 percent BSA (Sigma, St. Louis, Missouri or ICN) , 0.01 M
Tris-HCl buffer, pH 8.2 (Tris-BSA buffer). Columns were
poured to the dimensions of 1.0 x 2.0 cm or 1.0 x 6.0 cm. A
control column (1.0 x 2.0 cm) of uncoupled Sepharose 4B-C1
was prepared in a similar manner.
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Modifications of procedures reported by Akanuma et al
.
(Ill) were used for characterizing the coupled antibody
column. 125I-Insulin (0.68 uCi/ml, 7.2 ng/ml ICN, 1 to 3
ml) in a 1 percent BSA borate solution (0.1 M, pH 7.4) was
applied to the small column and allowed to equilibrate.
Column effluent was collected in ca 1.0 ml fractions and the
amount of radioactivity of each fraction was determined.
The column was washed with Tris-BSA buffer (20 ml, pH 8.2)
until no radioactivity was detected in the effluent, then
adsorbed radioactive peptides were eluted with 1 M acetic
acid (20 ml) . When no radioactivity could be detected in
the acid effluent, the column was reequilibra ted to pH 8.2
with Tris-BSA buffer (12 ml)
.
125 I-Gastrin with a specific activity of ca 700 uCi/ug
was diluted to ca 70 uCi/ml with a 0.02 M, Tris buffer pH
8.0. One half ml was equilibrated with the column and
binding was determined as described above.
A twenty-five ml of radioactive insulin solution (106
ng bovine insulin (Sigma)/ml, 7.2 ng 125 I-insulin (ICN)/ml
and 1.2 x 10 cpm/ml) was applied to the insulin antibody
column until it was saturated. When radioactivity of the
fractions had reached a plateau value, it was assumed that
maximum insulin binding capacity of the column had been
reached. The column was then washed with Tris-BSA buffer
(20 ml) until no radioactivity was detected in the effluent.
Bound insulin was eluted from the column with 1 M acetic
acid (20 ml). The column capacity was calculated from the
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total cpm eluted by the acid buffer and the specific
activity of labeled solution.
Mandue a sexta Ins ulin-Like Peptides : Separation from
Hemolymph
M. sexta hemolymph was obtained from fifth stadium
larvae by cutting off and bleeding through the abdominal
horn and then lyophilized.
A gram of freeze dried hemolymph (equivalent of about
20 ml fresh hemolymph) was extracted with 10 ml of 3 M
acetic acid. Six milliliters of Tris-BSA buffer pH 8.2 was
added to the lyophilized acid extract (440 mg) and 6 N
sodium hydroxide was used to adjust the pH to 8.2. The
suspension was centrifuged at 5,000 rpm (3,000 x g) in
Sorval RC2B centrifuge for twenty minutes. The supernatant
was decanted and saved. Another 6 ml of Tris-BSA buffer was
mixed with the precipitate and the centri fuga tion step
repeated. The two supernatants were combined and passed
through the large insulin antibody column. The column was
then washed with 12 ml Tris-BSA buffer, followed by 17 ml of
1 M acetic acid. One ml fractions of the acetic acid eluant
were collected. A 0.2 ml aliquot was removed from each
fraction, lyophilized and subjected to insulin
radioimmunoassay
.
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Apis mellifera Insulin-Like Pefit^ides_: Separation from Roya l
Jelly
A. Extraction of Royal Jelly
Royal jelly from the honeybee, Api s mellifera „ was
obtained from Dr. Nevin Weaver of the Dept. of Biology,
University of Massachusetts, Boston, Massachusetts and from
Formosa Joy Enterprises Co., LTD, Taiwan. The royal jelly
from Dr. Weaver had been collected in 1964, immediately
freeze dried, and stored under nitrogen in the deep freeze.
It was used for preliminary studies. The native royal jelly
obtained from Formosa Joy Enterprises was probably collected
in 1977 and sent to Manhattan in a frozen state. It was
then stored at -70°C until lyophilized and subsequently
stored -18°c until used. Approximately 0.4 g of lyophilized
royal jelly was the equivalent of 1 g of native royal
jelly.
The following procedure was routinely employed to
render the proteinaceous components of lyophilized royal
jelly suitable for chromatographic analysis (Figure 4). The
polypeptide components from 36 g of freeze dried royal jelly
were solubilized in 360 ml of a pH 7.7, 1 mM ammonium
acetate and 1 mM disopropyl fluorophospha te (DFP) solution.
The resulting solution was incubated at 4°C for at least one
hour. The sample was partially dilipidated by extraction
with 360 ml of diethyl ether. The biphasic mixture was then
centrifuged 7000 x g for one half hour, after which the
upper ether layer and interfacial material were discarded.
The remaining aqueous phase consisted of both soluble and
32
Figure 4. Scheme for the extraction and delipidation of
royal jelly.
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lyophilized, 36 gram
1. Add 360 ml buffer (1 M, pH 7.7
ammonium acetate and 1 mM DFP)
2. Incubate at 4° for 1-24 hrs.
3. Extract with 360 ml diethyl ether
4. Centrifuge, 7,000 g for 1/2 hr.
Lipid in diethylether phase and
interfacial material
(Discard)
Aqueous phase
1. Add 120 ml
concentrated
acetic acid
2. Mix
3. Recentrifuae at
7,000 g for 1/2 hr
Precipitate
(Discard)
Supernantant
(Ready for gel filtration)
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insoluble material . Most of the insoluble material was
solubilized by acidifying the suspension to a final
concentration of 3.5 M acetic acid. The solution was
recentr i fuged at 7,000 x g for one-half hour, the remaining
precipitate was discarded, and the supernatant was used for
gel filtration or stored in the freezer at -18°c.
B. Gel Filtration
Porous polyacrylamide beads (100 to 200 mesh), Bio-Gel
P-10, were obtained from Bio-Rad laboratories, Richmond
California. The beads had a fractionation range of 1,500 to
20,000 daltons . Approximately 40 g of dry Bio-Gel P-10 were
added to 800 ml of 3 M acetic acid. The gel was allowed to
hydrate for more than four hours at room temperature. Then
half the supernatant was decanted and the slurry was
deaerated by application of a partial vacuum. A 2.5 x 75 cm
column of Bio-Gel P-10 was prepared and equilibrated with
3 M acetic acid at ca 25 ml per hour overnight.
A four ml solution containing approximately 4 mg/ml of
bovine serum albumin (Sigma); 2 mg/ml bovine insulin
(Sigma); and 30,000 cpm/ml 14 c leucine (324 mCi/mM) was
applied to the column, eluted with 3 M acetic acid and
collected in a series of 130 tubes of 2.3 ml increments.
Relative amounts of protein in each increment of eluent were
estimated from its abs- . ~>ance at 280 nm in a Cary 118c
spectrophotometer. The amount of radioactivity in each
sample was determined by liquid scintillation counting of a
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. 25 ml sample
.
Five ml of centrifuged acid extract of royal jelly
(0.5 gm of lyophilized or 1.2 gm native royal jelly) was
chromatographed on the Bio-Gel P-l column. Fractions were
collected in 3.2 ml increments. Relative protein
concentrations were determined by absorbance of 280 nm in a
Cary 118c spectrophotometer. The samples were pooled for
radioimmunoassay into batches of 15 tubes each, beginning
with tube number 3 and lyophilized.
C. Radioimmunoassay
The pooled and lyophilized samples from the Bio-Gel
P-10 Chromatography were dissolved in water or 0.1 M,
ammonium bicarbonate, pH 8.0. Because residual acid from
the column buffer was present, the pH of the solution was
adjusted to 7.4 using 10 percent ammonium hydroxide and the
solution was lyophilized again. These steps (dissolving the
sample, adjusting the pH, and lyophilizing) were repeated a
second time to ensure that all residual acid was
volatilized. Then the lyophilized samples were dissolved in
2.5 ml of 10 mM phosphate buffer pH 7.4 containing 1 percent
BSA (ICN) . If the pH of the samples was below 7.2, it was
adjusted with small quantities of 10 percent ammonium
hydroxide to pH 7.4. One ml of the resulting solution was
transferred to each of two tubes and lyophilized. Samples
were redissolved in 0.25 ml distilled water for insulin
radioimmunoassay
.
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D. Affinity Chromatography
Sample pools that contained insulin-like
immunoreact ivi ty were subjected to affinity chromatography
on the large antibody column as follows: pools from a
series of 16 to 18 columns of gel filtration material were
combined and lyophilized. Material from each of the
consolidated pools was weighed and extracted in Tris-BSA
buffer two times with a volume of buffer which yielded an
initial concentration of 200 mg/ml . The pH was adjusted to
8.2 with 6 N sodium hydroxide before centrifuging the
solution at 5,000 rpm (3,000 x g) for twenty minutes. The
supernatants were decanted, pooled (final concentration 100
mg/ml) and subjected to affinity chromatography. The column
was then washed with about 15 ml of Tris-BSA buffer. The
effluent from the column was collected and assayed to
determine unadsorbed immunoreact ive insulin. Then the
column was washed with another 20 to 30 ml of a pH 8.2 M
Tris buffer (no BSA) . Adsorbed immunoreacti ve insulin was
eluted from the column with 1 M acetic acid and the
fractions were subjected to insulin radioammunoassay .
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RESULTS
Sources of Insect Insulin-like Polypeptides
Two tissues were used as starting material for
isolation of insulin-like polypeptides from insects. Royal
jelly from the honeybee, Apis mell if
e
ra , was utilized
because Dixit and Patel reported that it contained a peptide
(82) which elicited an insulin-like effect (glucose
oxidation) in vertebrate adipose tissue. Also Kramer et
al_. (83) described a peptide from royal jelly that induced
hypotrehalosemia in the tobacco hornworm and cross-reacted
with porcine insulin antiserum obtained from rabbits.
The other tissue used as a source of an insulin-like
polypeptide was hemolymph from Manduca sexta larvae. Since
hormones by classical definition are transported in blood
and Tager et a_.l. (70) described an insulin-like peptide in
certain neuroendocrine glands of M. sexta , hornworm
hemolymph seemed a logical starting material.
Insect Insulin Assay Sy stem : Problems Encountered with
B.adi o immunoassay
Bioassay and radioimmunoassay are the two methods most
used to detect insulin-like peptides. Bioassays are more
detailed, time consuming, not as reproducible, and usually
require a larger sample size than radioimmunoassay (RIA) to
produce a statistically sound assay. In general a
radioimmunoassay is cheaper, technically simpler to conduct
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and more sensitive and reproducible than bioassay
procedures. Radioimmunoassay was the method used in this
study of insect tissues.
Two different commercial insulin radioimmunoassay
systems were tried in these experiments. We first attempted
to use an inexpensive Research Products International (RPI)
component oriented system. RPI supplied guinea pig
anti-bovine insulin antibody serum, goat anti-guinea pig
serum, and guinea pig carrier serum. The RPI kit did not
provide buffer, insulin standards, or iodinated insulin.
Several problems were encountered with the use of the
RPI system. Optimal sensitivity of a radioimmunoassay is
obtained when approximately 50 percent of labeled hormone is
bound by antibody in the absence of unlabeled hormone (128).
With the RPI system, less than 5 percent of the tracer
125 I-porcine insulin (ICN) was bound by the anti-bovine
insulin antibody in the absence of standard bovine insulin.
An investigation was made to determine if the absence of
binding resulted from a lack of cross-reaction of the
porcine insulin with the anti-bovine insulin antibody.
Since porcine insulin differs from the bovine counterpart by
only two amino acids, (129) and since most antibodies to
porcine or bovine insulin are 98 percent cross-reactive
(130), it appeared that decreased cross-reactivity was not
the cause of our problem. Attempts to use a I-bovine
insulin tracer were also unsuccessful. We tried using a
homemade bovine insulin tracer (first with the original RPI
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system, second with the same system, but using a second
shipment of completely new antibodies which were guaranteed
functional by RPI, and third with the RPI system, new first
antibody, and ethylene glycol 6000 as the complex
precipitating agent). No tracer binding was observed in any
of these experiments. These results indicated that absence
of binding was not due to lack of cross-reactivity or to
defective antibodies.
1 25It was suspected that the I-peptide did not bind
because of soma other component present in the buffer
system. This apparently was the problem. A binding assay
was conducted with components which had been successfully
utilized in the RPI quality control lab. These
components— antibodies, 125 I-bovine insulin, and phosphate
buffered saline buffer (BSA-PBS)
—
produced about 30 percent
i 2S
I insulin binding. This binding did not occur, however,
when the homemade BSA-PBS buffer was used.
Thus , there were one or more components in the homemade
BSA-PBS buffer that prevented antigen antibody binding in
the RPI radioimmunoassay. Research Products personnel
suggested that some commercial forms of BSA were
contaminated with an " insulinase . " We had used BSA fraction
V from Sigma in our buffer. When the binding assay was
performed again, but this time utilizing a BSA-PBS buffer
made with purified BSA from RPI, about 50 percent of the
insulin binding capacity was restored. This result implied
both the Sigma BSA and other components of the BSA-PBS
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buffer prevented binding. Other components of the BSA-PBS
buffer system included salts, such as NaCl, Na^PO^ NaOH,
and EDTA. It is unlikely that interference resulted from
the reagent grade chemicals used here. RPI representatives
suggested that insufficiently purified water may also have
inhibited insulin binding. However, use of distilled water
gave satifactory results with other radioimmunoassays
performed in this lab. We did not investigate the RPI
radioimmunoassay system further because another commercially
available RIA system for insulin was found that was adequate
for our needs. The kit from ICN Medical Laboratories Inc.
provided necessary reagents. It produced 60 to 65 percent
12 5
I insulin binding in the absence of unlabeled insulin,
and detected as little as 500 pg mammalian insulin.
Extracti on of Insulin-like Peptides from Roy a 1 Jelly
The best extraction technique is one that results in
the selective solubilization of the desired peptide in a
protective solvent. This condition is often difficult to
achieve because numerous other peptides with similar
solubility properties are present. It is important to
extract under conditions that inactivate substances which
may damage the peptide or interfere with its assay.
Vertebrate insulin, like most peptides, is highly water
soluble and an aqueous solution with low salt concentration
can be used for its extraction. However, there is danger to
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the integrity of the insulin molecule from coextracted
proteolytic enzymes. This can be minimized by using
proteolytic enzyme inhibitors, extremes of pH, or heat
treatments as a part of the extraction procedure.
Protection of the insulin molecule is possible because it is
stable under these conditions and proteolytic enzymes are
not
.
Extraction methods for the insect insulin-like peptides
in royal jelly were developed to solubilize the peptides, to
remove substances which might interfere with the assay, and
to inactivate any proteolytic enzymes which may be present.
Acidification was used to solubilize the peptide components
of the sample. The solubilization and acidification of the
sample were performed at 4°C and in the presence of
disopropy 1-fluoro-phosphate (DFP, a serine hydrolase
inhibitor) to inactivate proteases which may have been
present. Royal jelly differs from ordinary sources of
insulin-like peptides because it has a relatively high lipid
content (about 16 percent on a dry weight basis (140)).
This lipid appeared to interfere with the radioimmunoassay.
The royal jelly was extracted with diethyl ether to remove
interfering lipids from the sample.
Gel Permeation Chromatography of Royal Jelly Immunoreactive
Insulin
The acid extract of royal jelly containing the
equivalent of 1.2 g native royal jelly, was chroma tographed
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on a Biogel P-l column in 3 M acetic acid. In Figure 5,
the elution volumes of BSA, bovine insulin, and 14 C-leucine
markers are shown. BSA with a molecular weight of 6.7 x 10
daltons was used to mark the void volume of the column
(109 ml); bovine insulin, the insulin-like peptide volume
(243 ml); and C-leucine , the inclusion volume of the
column (314 ml). Figure 5 also shows the elution profile of
royal jelly as measured by the absorbance at 280 nm of the
effluent. Two peaks were observed, one at the void volume
of the column and the other right before the inclusion
volume
.
In order to minimize the number of assays performed and
increase the amount of immunoreact ive insulin (IRI) in an
individual assay, pools of 15 tubes each beginning with
fraction 3 were collected from the column and lyophilized.
As shown in Figure 5, IRI was found in three of the eight
pools. Amounts detected were 2 . 4 ng in pool II (void
volume), 3.6 ng in VI (elution volume of bovine insulin) and
3.2 ng in VII (inclusion volume). IRI was not detected in
the remaining pools. The total IRI assayed in the eluant
was 9.2 ng porcine insulin equivalents or about 7.7 x 10
percent of the native royal jelly.
The pool II immunoreactive components have a relatively
large molecular weight, > 10,000 daltons. This may be an
aggregate of immunoreactive insulin or some precursor form
similar to vertebrate proinsulin. The former is unlikely
because the acidic solvent used does not favor association.
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Figure 5. Bio-Gel P-10 chromatogram of royal jelly extract.
The profile of absorbance at 280 am (• • ) obtained
after gel filtration of an acid extract of royal jelly
from Apis mel li fera has been superimposed on a bar graph
which indicates positions and quantities of immunoreacti ve
insulin found after assay of pools of the column effluent.
The arrows mark the elution position of the standards from
left to right: BSA, bovine insulin, ^- 4 C-leucine.
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The IRI in pool VI may correspond to the actual insect
insulin hormone, because it is similar in size to bovine
insulin. Some of the IRI found in pool VI and all of the
IRI found in pool VII is not insulin-like material as will
be explained below. It is actually composed of low
molecular weight substances that give a false positive
response in the radioimmunoassay.
Affinity Chromatography of Immunoreact ive Insul in from A.
me llifera Royal Je lly and M. sexta Hemolymph
Affinity chromatography was selected as the third step
in the isolation procedure for immunoreactive insulin-like
peptides in royal jelly. An affinity column with
anti-porcine insulin immunoglobulin coupled to agarose was
prepared as described in Materials and Methods.
A. Characterization of the Insulin Antibody Column
First, the possibility of nonspecific binding of
insulin to agarose (sepharose) was studied (Figure 6). In
each study, after a sample was applied to the column and the
column washed with pH 8.2 buffer, adsorbed material was
eluted with 1 M acetic acid. In Figure 6 the arrow
indicates where the acid elutant was added to the column
(fraction 20). When a standard solution of I-bovine
insulin was subjected to chromatography on a agarose column,
no radioactivity was adsorbed. All of the peptide eluted in
fractions 4-8. Thus, no interaction between insulin and
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Figure 6. Binding of 12 ^i-peptides to agarose and
anti-insulin globulin-coupled agarose. Sample was applied
in pH 8.2 buffer and adsorbed material eluted with 1 H
acetic acid beginning with fraction 20. A. Application of
1 25 I-insulin, 7800 cpm to agarose. B. Application of
^ 25i-insuiin , 24,000 cpm to antibody column. C.
Application of ^ 2 5i-g3S tr ^n t 15,000 cpm to the antibody
column
.
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agarose occurred under the conditions of sample
appl ica tion
.
Second, binding of insulin to the immunoglobulin
coupled agarose was measured (Figure 6B). Twenty-two
percent of the radioactivity applied did not bind to the
column and eluted in the pH 8.2 wash buffer. This material
may have been radiation damaged peptide or free1 r-^j.oactive
iodide derived from decomposition of iodinated paptides.
Adsorbed insulin eluted as a sharp peak in fractions 23-32
as the pH of the eluant decreased from 4.0 to 2.5. This
peak was 58 percent of the total counts added. Nineteen
percent of total counts added was unaccounted for. This
radioactivity may have been bound irreversibly to the column
material or have been lost in the background counts of the
eluant. Akanamu et al . (Ill) experienced a similar loss of
radioactivity (8 percent) with their column.
To determine reproducibility of insulin binding to the
immunoglobulin coupled agarose, the above experiment was
repeated twice using the same experimental conditions as
above but only one-third the quantity of tracer. In each of
the three trials, 20.6 + 1.1 percent of the I-material
was recovered in the wash buffer and 57.8 +0.9 percent was
eluted with 1 M acetic acid. Approximately 20 percent of
the radioactivity was always unaccounted for. From the
reproducibility of these results, it was concluded that
repeated acetic acid treatments did not change insulin
binding properties of the antibody column.
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The specificity of the insulin antibody coupled to
agarose was examined by determining whether another peptide
hormone would adsorb to the column. For this I-gastrin
was used (Figure 6C). No significant amount of gastrin was
adsorbed by the insulin antibody column. All of the
radioactivity eluted in fractions 4-11.
Another characteristic of the column determined was
binding capacity. A radioactive insulin solution (106 ug
insulin and 1200 cpm per ml solution) was applied to the
affinity column until a plateau of radioactivity was
achieved (Figure 7) . The column then was washed with pH 8.2
buffer until no significant radioactivity was recovered in
the effluent. Finally, one molar acetic acid was used to
recover the adsorbed insulin from the column. The total
binding capacity of the column was calculated from the
amount of radioactivity deadsorbed . The 1x6 cm column
bound 241 ug insulin. This is the equivalent of 23 ug of
insulin bound per mg of column bound immunoglobulin, 40 ug
per ml of packed resin or about one mole insulin bound per
mole IgG. Since two molecules of antigen bind one molecule
of antibody, approximately 1/2 of the IgG preparation is
composed of insulin specific binding protein. The results
of these experiments supported the expectation that the
affinity column would function in the manner of a specific
antigen-antibody reaction, and selectively bind insulin.
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Figure 7. Adsorption capacity of the insulin antibody
column. Twenty-five ml of a 106 ug/ml solution of
l 2 5i-insulin (1200 cpm/ml) was applied to a 1 x 6 cm
column in pH 8.2 buffer. Adsorbed radioactivity was
eluted with 1 M acetic acid (arrow)
.
51
ADSORPTION CAPACITY OF INSULIN-Ab COLUMN
10 20 30 40
TUBE NUMBER
50
52
B. Separation of Immunoreactive Insulin from Royal Jelly
and Hemolymph
After establishing that affinity column had the proper
specificity for insulin and enough capacity to handle our
tissue preparations, we next attempted to fractionate insect
insulin. The samples used were the Bio-Gel pools II, VI,
and VII and also an acid extract of hemolymph from M.
sexta. These materials were lyophilized and dissolved in pH
8.2 buffer at a concentration of 100 mg/ml before
application to the column.
The immunoreactive insulin from royal jelly in pool II
was adsorbed nearly completely by the RPI antibody column
and was recovered in 70 percent yield. This
immunoreactivity was composed of peptides with molecular
weights greater than 10,000 daltons and is termed high
molecular weight IRI for purposes of discussion. Not all of
the immunoreactive insulin from the royal jelly pools VI and
VII adsorbed to the affinity column. In fact no adsorption
was observed in pool VII. The pool VI immunoreactive
insulin had a molecular weight similar to or less than
vertebrate insulin. It contained both true immunoreactive
insulin (33 ng) which was adsorbed by the column antibody
and also some component (s) that yielded a falsely positive
response in the batch assay. Pools VI and VII eluted just
before and at the inclusion volume respectively. The
nonadsorbed immunoreactive insulin in pools VI and VII was
probably low molecular weight material which inhibited
tracer binding in the batch RIA assay.
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Yields of adsorbed IRI from royal jelly were 1.4, 1.5,
and ng per gram native jelly for pools II, VI, and VII
respectively or a total of 2.9 ng/g . Thus, the percentage
of dry weight of adsorbed IRI in native royal jelly was
2.9 x 10"" 7 percent.
We also used the affinity column to separate IRI from
M. sexta hemolymph. An acid extract from 1 g freeze dried
hemolymph was applied to the column and apparent
immunoreactive insulin was eluted both in the pH 8.2 buffer
(48 ng) and in the acid buffer (102 ng) . A total of 150 ng
equivalents of IRI was obtained by ICN assay. Like the
nonadsorbing material identified in royal jelly, the 48 ng
of nonadsorbed apparent IRI in hemolymph was probably not
peptide material. The 102 ng adsorbed by the column
— 5
antibody was 1 x 10 percent of the lyophilized hemolymph.
As observed with pool VI of royal jelly, the adsorbed
reactivity was composed of peptide material with an apparent
molecular weight of 5000 daltons (Kramer, K. J. and Childs,
- 9C. N., unpublished). Assuming this size, about 10 M
peptide was estimated to be present in the hemolymph.
However, this level is probably a low estimate since the
extraction procedure may not be completely efficient and
also since the affinity of the antibody for the insect
peptide is, in all probability, much less than that for the
vertebrate peptide.
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DISCUSSION
Radioimmunoassay and Separ at ion of Insulin- like Peptides
from Insects
Radioimmunoassay of peptide levels in biological
tissues is not a straightforward procedure. The results of
this study and other investigations have demonstrated that
such an assay is not reliable unless certain precautions are
taken. For example, initial attempts in this study to
determine insulin concentration failed because of the
presence of interfering substances in the assay buffer.
Further studies showed that valid estimates of insect
insulin could be obtained only in partially purified samples
and even these had to be corrected for interference from
substances that disrupt tracer peptide binding in the batch
a ssay .
Ishay et al. (85) and Kramer (unpublished) experienced
problems with radioassay of insect insulin. They could not
detect immunoreactive insulin in native royal jelly. Only
after subjecting the jelly to acid extraction, delipidation
and gel filtration was Kramer et al. (83) able to detect
25 ng insulin-like peptides per gram of native material. In
the present study, the Kramer et al. (83) procedure was
repeated, but only 7.7 ng immunoreactive insulin was
detected—about one-third the amount originally reported.
Since the fractionation procedures employed were the same in
both studies, the differences in the levels of apparent
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immunoreactive insulin could be attributed to different
sample sources, handling conditions and/or immunoassays.
Kramer et al. (83) obtained their royal jelly from U. S.
suppliers and used a rabbit anti-bovine insulin
radioimmunoassay system, while this study used royal jelly
from a company in Taiwan and a guinea pig anti-porcine
insulin system. In the present study, it was also
determined that estimates of insect insulin obtained from
these partially purified royal jelly samples had to be
corrected for the presence of false positive IRI material.
The use of a fourth clean-up procedure, affinity
chromatography, demonstrated that only 40 percent or 2.9 ng
of the 7.7 ng of apparent immunoreactive insulin detected
after gel filtration was true immunoreactive insulin. The
advantage of gel filtration followed by affinity
chromatography was that it allowed discrimination of true
immunoreactive species according to molecular size. Royal
jelly contained both an immunoreactive insulin similar in
size to vertebrate insulin and a larger immunoreactive
species, perhaps chemically similar to vertebrate
proinsulin. About half of this amount was similar in size
to vertebrate insulin, while the remaining IRI was large
molecular weight IRI.
Preliminary experiments with untreated M. sexta
hemolymph showed that some peptide clean-up procedure was
necessary before a valid radioimmunoassay could be
conducted. Based on previous experience with royal jelly
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IRI, it was decided to utilize affinity chromatography of a
hemolymph acid extract for such a clean-up. This worked
quite well and hemolymph was found to contain approximately
100 ng IRI per g dry weight. The heterogeneity of this
material was not determined in this study. Recently, Kramer
et a_l. (unpublished) have found that 70 percent of the IRI
in hornworm hemolymph is peptide material with an apparent
molecular weight of 5000 daltons.
These studies using insect hemolymph and royal jelly
describe the first attempt to isolate insulin from insects
using affinity chromatography. Traditional techniques, such
as ion-exchange chromatography or isoelectric precipitation,
were not used because of the low insulin content of our
starting materials. Affinity chromatography not only
fractionated our sample but also concentrated it to a level
where a radioimmunoassay could be reliably utilized.
The quantities of insect IRI fractionated here were
quite small because of the limited amount of tissue used.
If larger quantities of tissue become available, procedures
used here can be scaled up and used with other purification
steps, such as paper chromatography (95), polyacrylamide gel
electrophoresis, or ion-exchange chromatography (132) to
yield enough purified IRI for further chemical
characterization such as amino acid and sequence analyses.
If the amino acid sequence of insect IRI was found to
compare favorably with that of vertebrate insulin, then this
result would constitute the best evidence for the presence
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of insulin in insects. Also purified material could be used
in physiological studies to determine effects on
carbohydrate metabolism. In addition it could be used as an
immunogen for insect insulin specific antibody production.
Such antibodies could be used to develop a more specific and
sensitive radioimmunoassay for insect insulin and also to
prepare a more selective affinity chromatographic column.
Evolutionary Aspects of an Insulin-like Peptide in
Invertebra tes
Insects are a major class of the phylum Arthropoda
.
Arthropods are among the most advanced of all invertebrates
(102) and have many chemical characteristics similar to
vertebrates. Insulin-like peptides have been identified
previously by immunological and biological assays in three
orders of insecta : Hymenoptera (82,83), Lepidoptera (70),
and Diptera (76,81,84,98). The results of this
investigation have confirmed the presence of immunoreact ive
insulin in royal jelly from A. me 11 ifera and have
demonstrated for the first time an insulin-like peptide in
hemo lymph from M. sexta
.
The level of IRI in royal jelly was 2.9 ng/g native
tissue. Dixit and Patel (82) reported ca 70 times that
amount based on biological activity. The different results
may be explained by the fact that we used a heterologous
radioimmunoassay system (one that was developed using one
animal species and utilized in another) to identify in
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insects a peptide previously characterized in vertebrates
and Dixit and Patel used bioassay. The amino acid sequences
of peptides from different species have diverged during the
course of evolution. This divergence has frequently
occurred through single base mutations, and has generally
been conservative, resulting in little alteration in
biological function of many of the peptides. Species
differences in a hormone are, therefore, likely to occur in
regions of the molecule that are not directly involved in
its biological action and decreases in immunological
cross-reactivity are more likely than decreases in
biological activity. For example, guinea pig insulin has
almost full biological potency but less than 10 times the
immunochemical potency of other mamalian insulins in
immunoassay systems employing antibodies developed in man or
guinea pigs to beef or pork insulin (133). Insulins from
fish and many lower vertebrates are even more unreactive in
these systems (134).
With the scant amount of phylogenetic data available,
we could not predict apriori the degree of cross
immunoreac tivity between invertebrate and vertebrate
insulin-like peptides. However, it did appear that
cros s-immunologica 1 activity has been conserved in the
insulin peptide family (3,70,76,82,83,85,86,88,98,105).
Examination of available sequence data indicated that much
of the structure of insulin was conserved during evolution.
In fact, the human and porcine hormone are identical, while
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the bovine molecule differs by only 2 amino acids. Hagfish
insulin, the most primitive vertebrate hormone whose amino
acid sequence has been determined (106) , is approximately 80
percent conserved relative to the porcine hormone. Using
the rate of mutational acceptance for insulin of 4 accepted
point mutations per 100 residues per 100 million years and
an estimate of 900 million years since the divergence of
insects and mammals (63), it might be expected that insect
and vertebrate insulins may differ by about 40 percent in
sequence and that basic elements of their structures are
similar. Therefore, it is perhaps not surprising that a
heterogeneous population of antibodies for mammalian insulin
did cross-react with the insect insulin-like peptide found
in royal jelly, hemolymph, and other insect tissues
(70, 76, 83, 85,86,98)
.
Insects are not the only invertebrate class of animals
that respond to treatment with vertebrate insulin.
Vertebrate insulin caused effects such as glucose uptake,
glycogen synthesis or hypoglycemia in the following
invertebrate animals: a protozoan, Te trahymena pyriformjs
(99); a planarian, Polyce lis n igr a (101); a cestodian,
Taenia, crass iceps (10 0); a gastropod mollusc, Strophochejlus
oblongus (1); and some bivalve moluscs , Anodonta cygnea (3)
,
Unio pjctorum (3), and Meretrix ca sta (2). Insulin-like
biological activity (e.g., hypoglycemia, glycogen
deposition, and glucose oxidation) was observed when
extracts from invertebrates were assayed in vertebrate
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tissues (Table 2). The invertebrates tested include: the
clam, Mya arenaria (4), starfish, Pisas ter ochraceous (5)
and As terias rubens (103), snail, Hel ix pomati a (104) and
S trophoche ilus ob lo n^u s (105), crab, Callinectes sapidos
(160) and Carc inus maenas (51), sea squirt, CjLgna
in tertinalis (6), whelk, Buccinum unda turn (6), scallop,
Pecti n maximus (6), octopus, Eledone cirros a (6), and
oyster, Ostrea edulis (L.) (7). Insulin-like
immunoreactivi ty has been localized in gut tissue by
radioimmunoassay or immunocy tochemical analysis in the
bivalve molluscs, My tilus edulis (88), Anodonta cy gne a (3),
and Unio pic torum (3) , and the snail, S trophocheilus
oblongus (10 5)
.
The Physiological Function of Insulin-like Peptides in
Invertebrates
Although there may be some exceptions (73,75,93),
physiological functions of insulin in invertebrates
generally parallel those in vertebrates. These include
glucose uptake (96-101), hypoglycemia or hypotrehalosemia
(1-3), glycogen synthesis (3), and triglyceride release
(74). Concerning M. sexta , Tager et a_l. (70) demonstrated
hypotrehalosemic activity of immunoreact ive insulin from the
adult neurosecretory gland complex. They suggested that
these insulin-like peptides are secreted into the hemolymph
where they probably act on peripheral tissues to promote
sugar uptake and oxidation. The present study has confirmed
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that such a peptide is present in hemolymph, but further
study is required to determine how it functions
physiologically. The insulin-like peptide may produce
hypotrehalosemia by stimulating membrane transport of sugar
or by inducing an enzyme that metabolizes trehalose.
The level of insulin-like peptides in M. sexta
hemolymph determined by radioimmunoassay in this study was
5 ng insulin equivalents per ml. Actual levels may be
higher because of the probable low immunological
cross-reactivity of the antibody used. This concentration
is comparable to vertebrate levels which can range from 0.2
to more than 8 ng/ml (123) .
The function of the insulin-like peptides in royal
jelly remains to be determined, especially with regard to
whether or not it is indeed a hormone. Although the
polypeptide has biological activity and affects carbohydrate
metabolism in other animals (70,82), it has not been tested
physiologically in the honeybee; and we do not yet know if
it is released into the hemolymph for delivery to peripheral
tissues . Royal jelly is a secretion of the hypopharyngeal
glands of the honeybee adult and it is needed by the
developing larvae and queen bee. Perhaps the insulin-like
peptide plays a nutritional role related to the high
carbohydrate content of royal jelly (37 percent of dry
weight). The royal jelly insulin-like peptide may act to
promote normal growth of honeybee larvae (insulin promotes
differentiation and growth in both vertebrates and insects
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(79,80,83)) or it may have no biological function other than
being a protein food source. Unless the imnnunoreacti ve
insulin in royal jelly is bound to a protective carrier such
as lipid or another protein or is intrinsically resistant to
hydrolysis by the digestive proteases of the honeybee, it is
probably inactivated to small peptides and amino acids in
the insect gut. Further investigation is needed to explain
the physiological role of insulin in royal jelly.
Concluding Remarks
Fundamentally, it is not surprising that invertebrate
regulatory mechanisms are similar to those of the
vertebrates. We are now beginning to understand that
insects and vertebrates do use similar peptide hormones as
regulatory agents, as well as dissimilar ones (31). In
Part I of this thesis, we have provided further evidence
that insects use a peptide hormone similar to vertebrate
insulin. Although the chemical structure of the
immunoreactive insulin and the mechanism for its secretion
and action remains to be determined, its immunological and
biological similarities to the vertebrate counterpart
suggests that this hormone arose remarkably early during
animal evolution and has remained nearly constant and
widespread
.
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PART II
SOME EFFECTS OF VERTEBRATE ORAL HYPOGLYCEMIC
AGENTS IN INSECTS
66
INTRODUCTION
The discovery of physiologically active, insulin-like
polypeptides in the neuroendocrine system of insects
indicates that the invertebrate and vertebrate hypoglycemic
factors are related (70,82-85) and that pharmacological
agents which affect insulin action in vertebrates might
function similarly in insects. Oral hypoglycemic agents
such as phenformin, tolbutamide, and chlorpropamide lower
vertebrate blood sugar levels. Because this research was a
part of an overall study to determine how insects regulate
carbohydrate metabolism, we wished to determine whether
these drugs affect insects in a similar manner. If indeed
they did, then certain similarities between the insect and
vertebrate carbohydrate metabolism could be inferred.
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LITERATURE REVIEW
Qi§A Hypoglycemic Agents
Despite long usage of oral hypoglycemic drugs in
diabetes therapy, their exact mode of action in vertebrates
is not entirely understood, and nothing is known about their
effects in invertebrates. The following will summarize what
is known about the actions of these drugs in vertebrates.
A. Classes of Oral Hypoglycemic Agents
There are two major classes of oral hypoglycemic drugs,
the sulfonylureas and the biguanides. The common structural
components are R 1 -S0 2-NH-C-NH-R 2 and R 1 -NH-C-NH-2-NH 2
respectively where R, and R 2 are alkyl or aromatic
substituents (141). Figure 8 shows the chemical structures
of the three drugs used in this study: chlorpropamide,
tolbutamide and phenformin.
B. Mode of Action
For sulfonylurea compounds to be effective, a
functioning pancreas is required (150,151). The primary
action of acute administration is increased insulin release,
followed by decreased blood glucose levels (142). Chronic
sulfonylurea therapy eventually promotes decreased insulin
levels (143,144). The causes for these long term effects
are not well understood, but they may be due to an enhanced
glucose uptake by peripheral tissues, a decreased glucose
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Figure 8. Hypoglycemic drugs.
B. Tolbutamide; C. Phenformin
A. Chlorpropamide;
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output by liver (146-148), 3n increased number of binding
sites for insulin in target tissues (149), or a depletion of
insulin in the pancreas. Sulfonylureas are effective as
hypoglycemic agents in both the diabetic and nondiabetic
animal .
Biguanides such as phenformin are believed to lower
blood sugar levels by disrupting oxidative metabolism of
carbohydrates (accelerating anaerobic glycolysis) (152).
They have also been found to decrease glucose absorption
from gastrointestinal tract (125,153) and to inhibit hepatic
gluconeogenesis (125). Different species of animals show
varying hypoglycemic responses (108). Phenformin is an
extremely effective hypoglycemic agent in the monkey, guinea
pig, and diabetic human and rat (109).
Phenformin is the most active oral hypoglycemic agent
utilized in this study. It is followed by chlorpropamide.
Of the sulfonylureas, chlorpropamide is more active than
tolbutamide, probably because it is more slowly metabolized
(154) .
Side effects of the hypoglycemic drugs are most
pronounced with biguanide derivatives. The most common
effects observed with phenformin include tissue hypoxia,
lactic acidosis, anorexia, nausea, metallic taste, and
gastrointestinal disorder (125,154-15 6,159). Over doses of
either the biguanide or sulfonylurea drugs eventually lead
to hypoglycemic coma and death.
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MATERIALS AND METHODS
Hypoglycemic Drugs
Phenformin HCl [N- ( 2-pheny lethy 1 ) imidodicarbonimidic
diamide monohydrochloride] , chlorpropamide [4-chloro-N-
(propy lamino) carbony 1 benzenesulfonamide] and tolbutamide
[N- (buty lamino)carbony 1-4-methyl- benzenesulfonamide ] were
obtained from Ciba-Geigy Corporation, Ardsley, NY, Pfizer
Pharmaceuticals, Inc., Barceloneta, P.R. and Upjohn Co.,
Kalamazoo, MI., respectively.
In sec t Rearing Studies
A. Indian Meal Moth
Plodia interpunctella , Indian meal moth eggs were
obtained from Dr. W. H. McGaughey, Research Entomologist,
U. S. Grain Marketing Research Center, AR, SER, USDA,
Manhattan, Kansas, and were collected according to the
method of R. Kinsinger (113).
The diet for the Indian meal moth, Plodia
interpunctella, was made according to Kinsinger (113). It
consisted of 500 g coarse ground wheat, 500 g wheat shorts,
50 g wheat germ, 40 g Brewers yeast, 2 g sorbic acid and 2 g
methyl p-hydroxy benzoate. The latter two components were
added to prevent fungal growth. The dry ingredients were
thoroughly hand mixed before incorporating a mixture of
120 ml honey, 120 ml glycerin, and 60 ml distilled water.
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Phenformin was mixed with the diet in concentrations ranging
from 500 to 10,000 ppm. An appropriate number of phenformin
tablets were pulverized with mortar and pestle, suspended in
10 ml deionized water and mixed thoroughly with 100 g of
diet
.
Seventy-five Indian meal moth eggs were deposited on
top of each 100 g of treated diet in a 0.5 1 jar. Filter
paper was used as an air permeable lid for individual jars
and was held in place by a Mason jar ring. Feeding tests
were performed in duplicate at 27°C and 80 percent relative
humidity. The light cycle was 12 hours of light followed by
12 hours of dark. Adult insects were collected and counted
as they emerged. Approximately 30 days were required for
the development from egg to adult.
B. Tobacco Hornworm
Manduca sexta , tobacco hornworm eggs were obtained from
Dr. R. A. Reinecke, Research Entomologist, Metabolism and
Radiation Laboratory, AR, SEA, USDA, Fargo, North Dakota.
The method used to prepare diet for the tobacco
hornworm is the same as that reported by Bell and Joachim
(114). Diet was made by combining 240 g wheat germ, 108 g
casein, 96 g sucrose, 36 g Wessons salt mixture (Nutritional
Biochemical Corporation, Cleveland, Ohio), 48 g Brewers
yeast, 1 g cholesterol, 6 g sorbic acid, 3 g methyl
p-hydroxybenzoate and 0.5 g streptomycin. Then 60 g fine
ground agar was added to three liters of boiling water. The
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agar solution was allowed to boil for 2 or 3 minutes before
pouring it into a 1.5 gallon waring blender. The dry
ingredients were added while the blender was slowly
rotating. The mixture was thoroughly blended at high speed
before placing the blender container in cold water bath.
The medium was cooled to 24°C before replacing the blender
container on its base and adding 12 g ascorbic acid, 30 ml
vitamin solution (a mixture of 150 mg nicotinic acid, 75 mg
riboflavin, 35 mg thiamine, 35 mg pyridoxine, 35 mg folic
acid, 3 mg biotin, and 150 ml distilled water), 12 ml
linseed oil, and 60 ml of 4 percent formalin. The diet was
then mixed thoroughly for 2 minutes before pouring the
contents into a container.
The concentrations of phenformin in the agar based diet
ranged from 500 to 10,000 ppm; the concentrations of
chlorpropamide ranged from 4,500 to 10,000 ppm, and
tolbutamide was tested at only the 10,000 ppm level. The
three hypoglycemic agents were thoroughly mixed with the
partially cooled liquid agar medium which was then allowed
to solidify.
Feeding tests were conducted at 27°c and about 50
percent humidity in a Scherer, controlled light and
temperature growth chamber. The light cycle was 16 hours of
light followed by 8 hours of dark. Under these conditions,
approximately 33 days were required for the cycle from egg
to adult moth to be completed. After the eggs hatched, the
required number of larvae were left on the media while other
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larvae and any unhatched eggs were removed. The larvae were
weighed every two to four days. After the second stadium,
it was necessary to separate the larvae from each other to
avoid cannibalism. The larvae were observed closely at the
prepupae stage in order to determine whether they voided
their gut contents. Mold growth was likely unless the
rearing cups were cleaned. Placing a piece of filter paper
in the rearing cups was also helpful in absorbing moisture
and in preventing microbiological contamination.
C. Confused Fiou. r'oetle
Tribolium confusum, confused flour beetle eggs , were
obtained from the laboratory culture maintained at the U. S.
Grain Marketing and Research Laboratory, Manhattan, Kansas.
The growth medium for the confused flour beetle,
Tribolium confusum , was either coarsely ground whole wheat
or commercially purchased enriched white flour containing
ca . 3 percent Brewers yeast. Pulverized phenformin tablets
were added to the treatments to produce concentrations
ranging from 650 to 20,000 ppm phenformin.
Fifty confused flour beetle eggs were deposited on top
of 50 gm of treated diet in 5 cm deep by 8.5 cm wide clear
plastic cups. A loosely fitting clear plastic lid was used
to cover each cup. When the adults emerged, it was
necessary to tape the container closed to prevent their
escape. Feeding tests were performed in duplicate and
incubated at 27°C and 50 percent humidity in a Forma walk-in
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constant temperature and humidity chamber. The light cycle
was 12 hours of light followed by 12 hours of darkness.
Under these conditions, approximately 42 days were required
to complete the life cycle.
After the eggs hatched, a representative sampling of
the insects in each test were weighed at two day intervals
as follows: a fine sable hair brush was used to selectively
transfer 10 individuals from the rearing cups to tared
weighing paper. Care was taken to avoid transferring diet
to the paper. The insects were then weighed using a Mettler
H54 balance.
Dose-Mortality Relationships
The LC 50 is an estimate of the concentration of
dietary chemical that would kill 50 percent of a given
population. Data for this calculation was obtained by
dividing test animals into groups of moderate size and
giving each group one of a series of increasing
concentration of chemical. Mortality percentages were
calculated from the difference between the number of eggs or
larvae added and the adults that emerged. Values were
corrected for mortality in untreated samples. The corrected
mortality values were then used to establish the ppm of
chemical per weight of diet required to suppress 50 percent
of the control population (LC 50). Where statistically
possible, toxicity data was subjected to a 3 step probit
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analysis using a Wang 700 program (135/136) in order to
accurately determine the LC 50.
Effect of Chlorpropamide on Hemolymph Trehalose Levels and
Fat Body_ Glycogen in Toba cco Hornwo rm
A. Collection of Hemolymph and Fat Body from Manduca sexta
M. sexta larvae weighing 1.0 + 0.2 g were placed on a
diet containing 0.0 or 10,000 ppm chlorpropamide. The
larvae were allowed to feed (ca one day) until they weighed
2.2 + 0.3 g. The animals were weighed and then fasted for
at least one hour before cooling to 4°C, collecting the
hemolymph, and dissecting out the fat body (70,137). Both
hemolymph and fat body were guick frozen for storage. The
fat body was placed in a small vial before freezing and the
hemolymph wa3 collected by bleeding each larva into
individual test tubes containing a few crystals of 1-phenyl
2-thiourea (PTU) a phenol oxidase and trehalase inhibitor
(115) .
B. Purification and Quantitation of Hemolymph Trehalose
1. Saccharide Chromatography
Hemolymph trehalose was purified using the method of
Kramer et al. (117). Bio-Gel P-2 100 to 200 mesh porous
polyacrylamide beads were used to prepare a . 9 by 120 cm
column. The fractionation range of the Bio-Gel P-2 column
was 100 to 1,800 daltons. Trehalose (molecular weight of
342) is separated from glucose (molecular weight of 180) on
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this column. Methods used to prepare the column and apply
sample were similar to those described on page 34, except
that ca 27 g Bio-Gel P-2 and 200 ml of the column buffer,
20 mM Tris, 0.1 M NaCl buffer pH 7.3 were used in the gel
hydration step. The elution volumes of trehalose and
glucose from the P-2 column were determined by applying a
mixture of 100 ul each of 200 mM trehalose and 100 ul of
200 mM glucose to the column, eluting with the 0.02 M Tris,
0.1 M NaCl buffer, and analyzing successive 1.1 ml fractions
of the effluent for the sugars using the anthrone assay.
2. Anthrone Assay for Trehalose and Glucose
The anthrone reaction (116) was utilized to determine
neutral hexoses such as glucose and trehalose. In this
reaction furfural derivatives are formed in concentrated
sulfuric acid which reacts with the yellow anthrone reagent
to produce a blue green color. The anthrone reagent was
made by adding 720 ml of concentrated sulfuric acid to
280 ml water cooled in an ice bath. While the mixture was
still warm, 500 mg anthrone was added, allowed to stand
overnight and then thoroughly mixed.
The reaction was carried out in 13 by 100 mm pyrex
tubes containing 100 ul of the sample to be assayed. A
repipet was used to quickly add 1 ml anthrone reagent. Then
the tubes were vortexed , capped with a glass marble, heated
in a boiling water bath for 15 minutes and immediately
cooled to room temperature in a water bath before
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determining the absorbance of the solution at 620 nm on a
Beckman DU or a Cary 118c spectrophotomer . The amount of
sugar present in the hemolymph was quantitated by comparing
absorbance values with those obtained with 2 mM trehalose
and 2 mM glucose standards and using Beer's law (138).
Tubes with column buffer replacing the sample volume were
used as controls. Before any anthrone assays were performed
on unknown samples, ca 20 trehalose and glucose standards
were analyzed and an average standard absorbance was
determined. Each time an assay was performed, at least
three new standards were also analyzed and normalized to
previously determined standards.
C. Glycogen Level in Manduca sexta Fat Body
Glycogen determinations were made according to a
modification of the method of Carroll et a_l. (118). After
lyophilization of fat bodies, 4 to 6 mg of tissue were mixed
with 1 ml 30 percent KOH in a 5 ml pyrex centrifuge tube.
The tube was then placed in boiling water for 15 to 30
minutes or until the tissue dissolved, cooled to room
temperature and 15 mg Na
o
s0 4 added. Subsequently, 2 ml
absolute ethanol was added to precipitate the glycogen, the
tubes vortexed and allowed to stand overnight at 4°C before
centrifugation in the cold. The supernatant was decanted
and the precipitate redissolved in 1 ml of 0.5 percent KOH
after which the sample was again treated with 2 ml ethanol,
vortexed, incubated in the cold, centrifuged, and the
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supernatants discarded. The resulting precipitate was
redissolved in i ml 72 percent sulfuric acid and a 100 ul
aliquot was subjected to the anthrone assay for glucose.
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RESULTS
The Toxicity, of Chlorpropamide a nd Tolbutamide to Manduca
sexta
In order to determine physiologically active doses of
the sulfonylurea compounds in insects, we first conducted a
dose mortality study using the tobacco hornworm. An oral
feeding test was performed that tested levels up to 10,000
ppm of the drugs admixed with the diet. Chlorpropamide was
found to be the most toxic sulfonylurea . The chlorpropamide
LC 5 for M. sexta was ca 8.5 x 10-3 ppm or about 3.4 mM in
the diet (Table 3). Tolbutamide was less toxic and produced
ca 3 percent mortality when present at 10 ppm in the
diet
.
Th e Physiological Effect of Chlorpropam i d e in Manduca sexta
In order to determine whether chlorpropamide decreases
blood sugar in invertebrates as it does in vertebrates, we
fed the drug to last stadium larvae at approximately the LC
50 level and determined hemolymph trehalose and fat body
glycogen levels. Trehalose fell by 23 percent in the drug
treated animal from 54+4 to 42+2 mM (Figure 9) . No
effect was observed on fat body glycogen which remained at
about 450 umole glucose per gram of dessicated tissue.
Thus, chlorpropamide, a drug that induces insulin secretion
and hypoglycemia in vertebrates acted as a hy potrehalosemic
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Table 3. Diet levels of hypoglycemic drugs which
suppress 50 percent of the insect population.
JL
Manduca sexta
Drug LC 50 (ppm x 10_3 ) f
Chlorpropamide 8.5
Tolbutamide >10
Phenformin 1.1 (0.3-1.3)
Plodia interpunctelia "
Phenformin 3.3 (1.8-6.1)
Tribolium confusum
Phenformin 13 (10-19)
*5-20 neonate larvae tested per dose. Run in
duplicate.
'95 percent confidence limits given in paren-
thesis.
5 75 eggs added to medium treated homogeneously
with phenformin. Run in duplicate.
^50 eggs added to medium treated homogeneously
with phenformin. Run in duplicate.
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Figure 9. Effect of chlorpropamide on hemolymph trehalose
and fat body glycogen of M. sexta . Mean values + S.E.M.
from eight experimental animals are shown. Fourth instar
larvae (1.0 + 0.2 g) were placed on normal diet and diet
containing about 10^ ppm chlorpropamide. Animals weighing
2.2 + 0.3 g were sacrificed 1-2 days later.
(A) --Hemolymph trehalose content from control hornworms
(I) and hornworms fed diet supplemented with
chlorpropamide (II). (B)--Fat body glycogen content from
control (I) and chlorpropamide-treated (II) hornworms.
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agent in insects.
The Toxicity of Phen formin to Manduca sexta , Plodia
inte rpunctell a , and Tribo lium con fusum
Like the sulfonylurea drugs , the presence of phenformin
in the diet was detrimental to insect development, but
phenformin was about four times more toxic. The LC 50 for
the tobacco hornworm was 1.35 x 10 ppm (Table 3), while
that for chlorpropamide was only 8.5 x 10 J ppm. Generally,
as the amount of the phenformin in the diet was increased,
greater numbers of larvae expired and the time required for
pupation of surviving animals increased. Under standard
conditions, larvae grow for about 19 days until they undergo
pupal ecdysis (Figure 10). At 0.5-1.0 x 10 3 ppm phenformin,
pupal development took one or two days longer and at
2.5-3.0 x 10 ppm, none of the larvae were able to pupate.
The Indian meal moth showed a response to phenformin
much like the tobacco hornworm, except that Plodia was about
three times more tolerant with an LC 50 = 3.3 x 10 3 ppm. It
should be noted that this comparison may not be a reliable
one since the diets used for each species were quite
different in their physical make-up. The hornworm diet was
more homogeneous and it might be expected to be more
effective than the Indian meal moth diet in presenting a
uniform dose of drug to the consumer.
The confused flour beetle, Tribolium confusum, was the
species found to be least susceptible to phenformin in this
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Figure 10. Growth curves of M. sexta larvae fed standard
diet (-O-) and diets supplemented with phenformin: 500
(-•-), 1 x 10 3 (--), 2.5 x 10 3 (-**-), 3 x 10 3 (-O-), and
5 x LO 3 (--) ppm. D = death/ P = pupation.
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study. The LC 50 (1.3 x 10 4 ppnn) was about 10 times greater
than the hornworm's when the drug was admixed with the
enriched flour diet (Table 3). Again this comparison must
be interpreted cautiously because of the very different
nature of the two diets used. The concentration of
phenformin in the diet also affected the duration of the
Tribolium life cycle. At 2 x 10 4 ppm , only 34 percent of
the beetles developed to adults in ca 60 days whereas
untreated adults emerged in 40 days. A weight reduction
also occurred with the adult insects which survived the
phenformin treatment (Figure 11). For example beetles grew
to only 80 percent of their normal weight when fed
8-10 x 10 ppm phenformin. Accompanying abnormalities were
also noted in some of the beetles such as cuticle
discoloration and wing malformation. These observations
suggest that phenformin interferes with tanning chemistry
and imaginal disk development.
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Figure 11 . Effect of phenformin on the weight
confused flour beetle, Trjbolium confusum.
of the
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DISCUSSION
Sulfonylurea s ; Chlorpropamide and Tolbutamide
The results of this investigation suggest that
sulfonylurea drugs used in diabetes therapy have similar
actions in insects and vertebrates. When we examined the
effects of the sulfonylureas in insects, we found that
administering chlorpropamide and tolbutamide to the tobacco
hormworm inhibited development with the former drug being
the more effective. In vertebrates, chlorpropamide is the
more active hypoglycemic agent and presumably is also the
more toxic drug (125). Our investigation also demonstrated
that chlorpropamide depressed the blood carbohydrate level
in the tobacco hornworm, producing a hypotreha losemic effect
that is similar to the hypoglycemia observed in vertebrates
after sulfonylurea administration. The physiological effect
of tolbutamide was not determined.
The acute action of sulfonylurea drugs in vertebrates
is beta-cell degranula tion and insulin release from the
pancreas (125). We propose that similar mechanisms operate
in insects. Insulin-producing cells in insects analogous to
pancreatic beta-cells may be stimulated by sulfonylurea
agents to release insulin and produce a hypotrehalosemic
state .
The other insulin effect that was looked for in insects
upon administration of chlorpropamide was an increase in fat
body glycogen levels. Such a response was anticipated
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because insulin has this effect in vertebrate tissues.
However no increases in glycogen levels were observed.
Observations similar to ours were reported by Tager et al .
(70) who injected M. sexta larvae with immunoreactive
insulin from insect neurosecretory tissue. These injections
only decreased blood sugar and did not increase glycogen
levels in fat body. The overriding effect of chlorpropamide
treatment may have been increased trehalose utilization and
oxidation by peripheral tissues.
This study provided suggestive evidence for the
presence of cells in insects that produce insulin. It is
interesting to note that alloxan and s treptozotocin , drugs
used experimentally to selectively destroy pancreatic
beta-cells in vertebrates and cause hyperglycemia (diabetes)
and death, have physiological and toxic activities in
insects. Ishay (110) found that feeding alloxan to Vespa
orientalis larvae led to a marked increase in salivary
glucose levels and caused death in a few days. Kramer et
al . (126) found alloxan and s treptozotocin to be lethal to
M. s exta larvae at levels similar to effective doses for
vertebrates (50-200 mg/kg body weight). In a histological
study, alloxan injection caused cells in the corpus
cardiacum, a neurosecretory organ which apparently secretes
insulin in insects, to degenerate (Speirs , R. D. and Kramer,
K. J. unpublished) . All of these studies support the
hypothesis that insects contain insulin producing cells in
the neuroendocrine system and that the insulin-like peptide
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is the hypotrehalosemic hormone.
Bigu anides : Phenformin
We have less information on phenformin action in
insects than we have on sulfonylurea action. All we know is
that phenformin was at least 8 times more toxic than the
sulfonylurea agents to insects. This trend is similar to
that observed when vertebrate hypoglycemic activities of
these two kinds of drugs are compared . In vertebrates
phenformin is usually about 2 times more effective than
chlorpropamide (125) . This comparison of drug action is not
a straightforward one since vertebrates take these drugs in
carefully measured doses while the insects were fed the drug
ad libi tum admixed with diet.
The toxicity of phenformin to insects may result from
an action on carbohydrate metabolism similar to that
observed in vertebrates. The demonstration of
hypotrehalosemia following phenformin administration would
provide direct evidence for such an action.
The toxicity of phenformin was dependent on the species
of insect tested. The confused flour beetle was four and
twelve times less susceptible to the drug than the Indian
meal moth and tobacco hornworm, respectively, This suggests
that beetle species may be more resistant to the biguanide
drug than are moth species. It was also evident that the
two stored product insects, P
1
od
i
a and Tr jbolium, were more
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tolerant of phenformin than the phytophagus insect,
Manduca . In general stored product insects are found to be
more hardy than are insects with a dietary requirement for
fresh plants (138)
.
One other factor must be considered when making
toxicological comparisons such as we have done, that is, the
type of diet used. Each of our experimental animals were
fed on a different type of diet. Manduca fed on a
semiartif ici al agar based diet that was relatively
homogeneous. Tr ibplium fed on a coarsely ground whaat
medium that was very heterogeneous. We found that diet
consistency probably plays a negligible role in determining
toxicity levels since phenformin had the same toxicity
(within experimental error) to Tribolium in both the ground
wheat and flour diets. If heterogeneity was important, then
phenformin might have been expected to be more toxic to
Tribolium in flour than in ground wheat.
Concluding Rema rks
The stresses caused by the sulfonylureas in insects
could very well be hypotreha losemic hormone (insulin)
-
mediated responses. Just as in vertebrates, the
sulfonylurea compounds may increase insulin output in
insects with resultant lowered blood sugar and death at high
doses. Our results in both Part I and Part II of this
thesis, together with those of others, support the
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hypothesis that insects have the potential to suffer from
pathological states due to insulin over or under production.
In view of these conclusions, it is interesting to note that
the hyperglycemia associated with cautery of the medial
neurosecretory cells of the Calliphora brain results in
manifestations (i.e., polydipsia) similar to conditions of
vertebrate insulin underproduction, diabetes (30).
The insecticidal action of the biguanide derivative may
result from actions on carbohydrate metabolism similar to
that observed in vertebrates, i.e., increased glycolysis,
decreased gluconeogenesis , and decreased glucose absorption.
However, to fully determine whether the true pharmacological
action of either the sulfonylureas or the biguanides is as
stated above, more detailed studies such as biochemical,
morphological, histological and immunocy tochemical analyses
of their effects are needed. As has previously been done
with vertebrates, it should be determined whether
hyper insulinemia also occurs in our invertebrate animals
under the influence of sulfonylurea administration. If
indeed these vertebrate agents prove to kill insects by
disrupting carbohydrate metabolism, then it might be
worthwhile to develop a screening procedure to search for
chemicals that are active in pest insects and not in
vertebrates. Such compounds may have potential for use as
pesticides
.
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This research was part of an overall study to determine
how insects regulate carbohydrate metabolism. In the first
part of this thesis, the partial purification of
hypotrehalosemic , insulin-like factors from hemolymph of the
tobacco hornworm, Manduca sex ta and from royal jelly of the
honeybee, Apis mellifer a , is described. An insulin-like
peptide from the hornworm was partially purified by acid
extraction of lyophilized hemolymph and subsequent affinity
chromatography on agarose coupled to anti-insulin
immunoglobulin. Honeybee immunoreactive insulin was
partially purified by acid extraction of lyophilized royal
jelly, delipidatation , gel filtration, and affinity
chromatography. Two different royal jelly insulin-like
peptides were detected. One peptide had a rather high
molecular weight (> 10 4 ) and the other was approximately the
size of bovine insulin (5 x 10 ) . The quantities of
insulin-like peptides present in hemolymph and royal jelly
were determined using insulin radioimmunoassay. The yield
of immunoreactive insulin from M. s ext a hemolymph was
1 x 10" gram porcine insulin equivalents per gram of
— 9lyophilized hemolymph or 5 x 10 gram per ml of native
hemolymph. The concentration of immunoreactive insulin in
— 9hemolymph was 10 M. The yield of immunoreactive insulin
— 9from royal jelly was 1.4 and 1.5 x 10 gram per gram of
native royal jelly for the high and low molecular weight
forms, respectively.
The second part of this thesis was concerned with the
effect of vertebrate hypoglycemic agents in insects. The
oral toxicity (LC 50) of chlorpropamide, tolbutamide and
phenformin for the tobacco hornworm was 8.5 x 10 3
, io 4 , and
1.1 x 10 ppm in diet, respectively. Chlorpropamide at
10 ppm in the diet lowered blood sugar levels by 23
percent, but did not change fat body glycogen levels.
Phenformin was toxic to the Indian meal moth and confused
flour beetle with LC 50 values of 3.3 x 10 3 and 13 x 10 3 ,
respectively. Phenformin also delayed maturation and caused
cuticle discoloration and malformation in the latter
species. The confused flour beetle was more resistant to
phenformin than the two moth species while the two stored
product insects (Indian meal moth and confused flour
beetle), were more tolerant of the drug than the n"*y tophagus
insect (tobacco hornworm).




